607 TRICUSPID VALVE IN VALVE AND RENAL ARTERY ANGIOPLASTY: A RARE CASE OF HEART FAILURE TREATED BY TWO MINIMALLY INVASIVE INTERVENTIONAL PROCEDURES

• Published in: European heart journal supplements Vol. 24; no. Supplement_K
• Main Authors: Bandini, Marta, Cesarini, Daniel, Mattesini, Alessio, Meucci, Francesco, Di Mario, Carlo
• Format: Journal Article
• Language: English
• Published: 15.12.2022
• ISSN: 1520-765X; 1554-2815
• DOI: 10.1093/eurheartjsupp/suac121.288

Abstract Tricuspid valve pathology has unfavorable anatomy for repair and valve replacement is often required. Biological tricuspid valves have a shorter lifespan compared to aortic and mitral prostheses and their replacement is considered a high-risk procedure. In addition, patients with tricuspid valve disease have multiple comorbidities and a reduced functional class, which contribute to an increased risk of mortality. The recent spread of percutaneous valve treatments has demonstrated a good safety profile and a high short-term success rate. Regarding nephrovascular hypertension, it is still a matter of debate whether there is a long-term benefit of renal artery angioplasty plus medical therapy over medical therapy alone. According to recent evidence, revascularization would provide benefit only in specific circumstances such as, failure of optimal medical therapy, relapsing episodes of acute pulmonary edema and refractory heart failure. We present the case of a 62-years-old woman with right heart failure associated with prosthetic tricuspid valve dysfunction and nephrovascular hypertensive crisis, treated by two minimally invasive interventional procedures, with excellent short-term clinical outcome Tricuspid valve in valve procedure Renal artery angioplasty